Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rHuPH20 Pretreatment with CSII in Type 1 Diabetes
NCT01526733Phase 4Completed
- Sponsor
- Halozyme Therapeutics, Inc.
- Start
- Dec 2011
- Primary completion
- Aug 2012
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of hyaluronidase in type 1 diabetes mellitus (T1D), sponsored by Halozyme Therapeutics, Inc.. Started Dec 2011; status: completed.
02
Drugs
hyaluronidase
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01526733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01526733.